Expression of BMP-7 in human gastric cancer and its clinical significance

British Journal of Cancer

Volumn 104, Issue 4, 2011, Pages 714-718

  Aoki, M ^a   Ishigami, S ^a   Uenosono, Y ^a   Arigami, T ^a   Uchikado, Y ^a   Kita, Y ^a   Kurahara, H ^a   Matsumoto, M ^a   Ueno, S ^a   Natsugoe, S ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

BMP 7; gastric cancer; histology; nodal involvement; prognosis

Indexed keywords

OSTEOGENIC PROTEIN 1;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RISK; CELL MEMBRANE; CLINICAL FEATURE; CYTOPLASM; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 7; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79951669909     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606075     Document Type: Article

References (31)

1. Alarmo EL, Korhonen T, Kuukasjävi T, Huhtala H, Holli K, Kallioniemi A (2008) Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol 19(2): 308-314 (Pubitemid 351201712)
2. Alarmo EL, Pärssinen J, Ketolain JM, Savinainen K, Karhu R, Kallioniemi A (2009) BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett 275(1): 35-43
3. Alarmo EL, Rauta J, Kauraniemi P, Karhu R, Kuukasjävi T, Kallioniemi A (2006) Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer 45(4): 411-419 (Pubitemid 43346773)
4. Andrews PW, Damjanov I, Berends J, Kumpf S, Zappavigna V, Mavilio F, Sampath K (1994) Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 71(2): 243-251 (Pubitemid 24278177)
5. Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477
6. Cao X, Chen D (2005) The BMP signaling and in vivo bone formation. Gene 357: 1-8 (Pubitemid 41267309)
7. Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22: 233-241 (Pubitemid 40136452)
8. Ducy P, Karsenty G (2000) The family of bone morphogenetic proteins. Kidney Int 57: 2207-2214 (Pubitemid 30340719)
9. Dudley AT, Lyons KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9(22): 2795-2807
10. Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endcr Metab Disord 7(1-2): 51-65 (Pubitemid 46044349)
11. Grijelmo C, Rodrigue C, Svrcek M, Bruyneel E, Hendrix A, de Wever O, Gespach C (2007) Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell Signal 19(8): 1722-1732 (Pubitemid 46935428)
12. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1: 10-24
13. Kwak C, Park YH, Kim IY, Moon KC, Ku JH (2007) Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma. J Urol 178(3 Part 1): 1062-1067 (Pubitemid 47211049)
14. Lombardo Y, Scopelliti A, Cammareri P, Tadaro M, Iovino F, Ricci-Vitiani L, Gulotta G, Dieli F, De Maria R, Stassi G (2011) BMP4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140(1): 279-309
15. Luo DD, Phillips A, Fraser D (2010) Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via SnoN expression. Am J Pathol 176(3): 1139-1147
16. Luo G, Hoffmann C, Bronckers AL, Sohochi M, Bradley A, Karsent G (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9: 2808-2820
17. Masuda H, Hukabori Y, Nakano K, Shimizu N, Yamanaka H (2004) Expression of bone morphogenetic protein-7 (BMP-7) in human prostate. Prostate 59(1): 101-106 (Pubitemid 38387847)
18. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387(6628): 83-90 (Pubitemid 27202654)
19. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M (2008) Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol 15(5): 1530-1537
20. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108 (Pubitemid 40372904)
21. Ro TB, Holt RU, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, Sundan A, Borset M (2004) Bone morphogenetic protein-5,-6 and-7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 23(17): 3024-3032 (Pubitemid 38648193)
22. Rothhammer T, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hein R, Hofstaedter F, Bosserhoff AK (2007) Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark 3(2): 111-117 (Pubitemid 47103812)
23. Solloway MJ, Robertson EJ (1999) Early embryonic lethality in Bmp5: Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126(8): 1753-1768 (Pubitemid 29204338)
24. Sulzbacher I, Birner P, Trieb K, Pichlbauer E, Lang S (2002) The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol 55(5): 381-385 (Pubitemid 34494179)
25. Urist MR (1965) Bone: formation by autoinduction. Science 150: 893-899
26. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RW, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242(4885): 1528-1534 (Pubitemid 19023695)
27. Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, Altieri DC, Roy-Burman P (2006) Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Cancer Res 66(8): 4285-4290
28. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P (2005) Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65(13): 5769-5777 (Pubitemid 40911180)
29. Yokomakura N, Natsugoe S, Okumura H, Ikeda R, Uchikado Y, Mataki Y, Takatori H, Matsumoto M, Owaki T, Ishigami S, Aikou T (2007) Improvement in radiosenseitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma. Oncol Rep 18(3): 561-567
30. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R (2003) BMP-7 counteracts TGF-/í1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9(7): 964-968 (Pubitemid 36889942)
31. Zwijsen A, Verchueren K, Huylebroeck D (2003) New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett 546: 133-139 (Pubitemid 36782294)